Flexi-T® Important Safety Information

Flexi-T® IUD does not protect against HIV/AIDS or other sexually transmitted infections. You must not use Flexi-T® if you currently have acute Pelvic Inflammatory Disease (PID) or engage in current behavior suggesting a high risk for PID.

Flexi-T® is also not an option for women who might be pregnant, have a uterus that is abnormally shaped, have had a post-pregnancy or post-abortion uterine infection in the past 3 months, have cancer of the uterus or cervix, have unexplained bleeding of the vagina, have an infection in the cervix, have an allergy to any component of Flexi-T®, have Wilson's disease or already have an intrauterine contraceptive in the uterus.

The most common side effects of Flexi-T® are heavier and longer periods for a few months after placement; some women have spotting between periods. For most women, this typically subsides after a few months. However, if your menstrual flow is severe or prolonged, call your healthcare professional. You should also call your healthcare professional without delay if you miss a period as you might be pregnant.

Some possible serious complications that have been associated with intrauterine contraceptives, including Flexi-T®, are PID, perforation of the uterus, expulsion (where the contraceptive falls completely or partially out of the uterus), and difficult removals (where the contraceptive becomes stuck in the uterus and occasionally requires surgery to remove it).

If any of these complications arise it is then critically important to seek the advice of a health care professional. Nothing on this Website should be construed as the giving of advice or the making of a recommendation, and it should not be relied on as the basis for any decision or action. It is important that you rely only on the advice of a healthcare professional to advise you on your specific situation.

We do not offer a replacement program for the Flexi-T IUD and it’s because of this policy that we are
able to maintain the low cost of Flexi-T IUD and therefore making this product assessable to all women across Canada.

Expulsion are always a possibility and patients should be advised of this possibility.